Cargando…

The Consistency Between the Chinese Essential Medicines List and Treatment Guidelines—Taking Oncology Medicines as an Example

The concepts of “essential medicine” and “national medicine policy” were first put forward for the first time at the World Health Assembly in 1975 in an effort to alleviate the problem of medicine unavailability in developing and poor countries. The essential medicine system in China has experienced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Luyan, Li, Caiyun, Zhang, Xuefang, Chen, Yongfa, Yan, Jianzhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301269/ https://www.ncbi.nlm.nih.gov/pubmed/35874976 http://dx.doi.org/10.3389/fpubh.2022.943994

Ejemplares similares

Degarelix vs. leuprorelin for the treatment of prostate cancer in China: A cost-utility analysis
por: Yan, Jianzhou, et al.
Publicado: (2022)

Assessing variation among the national essential medicines lists of 21 high-income countries: a cross-sectional study
por: Taglione, Michael Sergio, et al.
Publicado: (2021)

Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List
por: Gotham, Dzintars, et al.
Publicado: (2019)

Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO
por: Piggott, Thomas, et al.
Publicado: (2022)

Access and use of WHO essential medicines in Italy
por: Petrella, Alessandro, et al.
Publicado: (2023)

The Survey on Adolescents' Cognition, Attitude, and Behavior of Using Analgesics: Take Sichuan and Chongqing as an Example
por: Yin, Lian, et al.
Publicado: (2022)

Accessibility of essential anticancer medicines for children in the Sichuan Province of China
por: Chen, Zhe, et al.
Publicado: (2022)

Public opinion communication mechanism of public health emergencies in Weibo: take the COVID-19 epidemic as an example
por: Ren, Siguo, et al.
Publicado: (2023)

A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines
por: Mustafa, Asma Abubakr, et al.
Publicado: (2010)

Are the epidemic prevention facilities effective? How cities should choose epidemic prevention facilities: Taking Wuhan as an example
por: Hua, Lei, et al.
Publicado: (2023)

Research on the influence of patient cost-sharing on medical expenses and health outcomes: Taking patients with heart failure as an example
por: Zhang, Huyang, et al.
Publicado: (2023)

Analysis and prediction of improved SEIR transmission dynamics model: taking the second outbreak of COVID-19 in Italy as an example
por: Lu, Ming, et al.
Publicado: (2023)

Monographs for medicines on WHO’s Model List of Essential Medicines
por: Roth, Lukas, et al.
Publicado: (2018)

Back to the ‘essence’ of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines
por: Eniu, Alexandru, et al.
Publicado: (2016)

Analysis of the impact of urban summer high temperatures and outdoor activity duration on residents' emotional health: Taking hostility as an example
por: Huang, Huanchun, et al.
Publicado: (2022)

An Ontology-Based Artificial Intelligence Model for Medicine Side-Effect Prediction: Taking Traditional Chinese Medicine as an Example
por: Yao, Yuanzhe, et al.
Publicado: (2019)

Systematic Review and Quality Evaluation of Pharmacoeconomic Studies on Traditional Chinese Medicines
por: Yang, Nan, et al.
Publicado: (2021)

Mind-Body Therapies From Traditional Chinese Medicine: Evidence Map
por: Fogaça, Lissandra Zanovelo, et al.
Publicado: (2021)

Global Trade Pattern of Traditional Chinese Medicines and China's Trade Position
por: Xiang, Liyao, et al.
Publicado: (2022)

Me‐too pharmaceutical products: History, definitions, examples, and relevance to drug shortages and essential medicines lists
por: Aronson, Jeffrey K., et al.
Publicado: (2020)

A Study of Family Process Factors of Social Anxiety on the Internet Based on Big Data—Take Guangxi University Students as an Example
por: Bi, Dexu
Publicado: (2022)

Research on the dynamic spillover of stock markets under COVID-19—Taking the stock markets of China, Japan, and South Korea as an example
por: Zhou, Baicheng, et al.
Publicado: (2022)

Oncology nursing on the move: a contemporary issue on Chinese oncology nursing in cancer care
por: Li, Yingyang, et al.
Publicado: (2023)

Availability of essential medicines, progress and regional distribution in China: a systematic review and meta-analysis
por: Zhang, Miao, et al.
Publicado: (2023)

Withdrawn medicines included in the essential medicines lists of 136 countries
por: Charles, Onella, et al.
Publicado: (2019)

Biologic medicine inclusion in 138 national essential medicines lists
por: Kraus, Raphaël, et al.
Publicado: (2021)

Modeling Rumor Diffusion Process With the Consideration of Individual Heterogeneity: Take the Imported Food Safety Issue as an Example During the COVID-19 Pandemic
por: Chen, Tinggui, et al.
Publicado: (2022)

Dermatologic Surgery and Dermatologic Oncology as an Essential Part of the Modern Dermatology in Bulgaria
por: Tchernev, Georgi, et al.
Publicado: (2017)

Novel Coronavirus Pneumonia Treatment With Traditional Chinese Medicine: Response Philosophy in Another Culture
por: Li, Zhuman, et al.
Publicado: (2020)

Equity and Efficiency of Health Resource Allocation of Chinese Medicine in Mainland China: 2013–2017
por: Li, Zhengjun, et al.
Publicado: (2020)

Non-occupational lead poisoning associated with traditional Chinese medicine: A case report
por: Ma, Huan, et al.
Publicado: (2022)

Topic evolution and sentiment comparison of user reviews on an online medical platform in response to COVID-19: taking review data of Haodf.com as an example
por: Li, Chaoyang, et al.
Publicado: (2023)

Essential tuberculosis medicines and health outcomes in countries with a national essential medicines list
por: Maraj, Darshanand, et al.
Publicado: (2022)

Comparison of essential medicines lists in 137 countries
por: Persaud, Nav, et al.
Publicado: (2019)

The case for levetiracetam to be included in essential medicine lists
por: Singh, Gagandeep, et al.
Publicado: (2023)

Effect of the full coverage policy of essential medicines on medication adherence: A quasi-experimental study in Taizhou, China
por: Guo, Zhigang, et al.
Publicado: (2022)

Acceptability of Traditional Chinese Medicine in Chinese People Based on 10-Year's Real World Study With Mutiple Big Data Mining
por: Guo, Yan, et al.
Publicado: (2022)

Evaluation of Availability, Prices, and Affordability of Selected Essential Medicines in Balochistan, Pakistan
por: Bibi, Murad, et al.
Publicado: (2022)

Corporate financialization, financing constraints, and innovation efficiency—Empirical evidence based on listed Chinese pharmaceutical companies
por: Zhu, Jialin, et al.
Publicado: (2023)

Quantitative evaluation of traditional Chinese medicine development policy: A PMC index model approach
por: Yang, Ciran, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q9o6t3kvg6vfaerrkcoee8t772